ResMed Inc/ US7611521078 /
| 2024-11-12 8:43:03 PM | Chg. -1.93 | Volume | Bid- | Ask2024-11-12 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 246.89USD | -0.78% | 15,473 Turnover: 3.83 mill. |
-Bid Size: - | 247.06Ask Size: 205 | 36.26 bill.USD | 0.78% | 35.59 |
Assets
| 2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 387.4600 | 417.3350 | 463.4900 | 498.1810 | 537.8560 | ||||||
| Intangible Assets | 521.9500 | 448.1680 | 392.5820 | 345.9440 | 552.3410 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 2,962.3160 | 3,063.9170 | 3,153.3680 | 3,164.3750 | 4,383.8780 | ||||||
| Inventories | 349.6410 | 416.9150 | 457.0330 | 743.9100 | 998.0120 | ||||||
| Accounts Receivable | 528.4840 | 474.6430 | 614.2920 | 575.9500 | 704.9090 | ||||||
| Cash and Cash Equivalents | 147.1280 | 463.1560 | 295.2780 | 273.7100 | 227.8910 | ||||||
| Current Assets | 1,145.3660 | 1,523.4590 | 1,574.7570 | 1,931.4780 | 2,367.8300 | ||||||
| Total Assets | 4,107.6820 | 4,587.3760 | 4,728.1250 | 5,095.8530 | 6,751.7080 | ||||||
Liabilities
| 2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 115.7250 | 135.7860 | 138.0080 | 159.2450 | 150.7560 | ||||||
| Long-term debt | 1,258.8610 | 1,164.1330 | 643.3510 | 765.3250 | 1,431.2340 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | - | - | - | - | - | ||||||
| Liabilities | 2,035.4890 | 2,090.3490 | 1,842.4460 | 1,735.1020 | 2,621.8050 | ||||||
| Share Capital | .5750 | .5800 | .5830 | .5860 | .5880 | ||||||
| Total Equity | 2,072.1930 | 2,497.0270 | 2,885.6790 | 3,360.7510 | 4,129.9030 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 4,107.6820 | 4,587.3760 | 4,728.1250 | 5,095.8530 | 6,751.7080 | ||||||
Income Statement
| 2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2,606.5720 | 2,957.0130 | 3,196.8250 | 3,578.1270 | 4,222.9930 | ||||||
| Depreciation (total) | 150.7950 | 154.8500 | 156.7580 | 159.6090 | 165.1560 | ||||||
| Operating Result | 579.2630 | 809.6590 | 903.6780 | 1,000.2860 | 1,131.8710 | ||||||
| Interest Income | -33.8570 | -39.3560 | -23.6270 | -22.3120 | -47.3790 | ||||||
| Income Before Taxes | 518.8470 | 733.0880 | 883.6620 | 960.4830 | 1,101.6640 | ||||||
| Income Taxes | 114.2550 | 111.4140 | 409.1570 | 181.0460 | 204.1080 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 404.5920 | 621.6740 | 474.5050 | 779.4370 | 897.5560 | ||||||
Per Share
Cash Flow
| 2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 459.0510 | 802.2550 | 736.7180 | 351.1470 | 693.2990 | ||||||
| Cash Flow from Investing Activities | -1,075.7060 | -179.8610 | -158.4620 | -229.9180 | -1,159.8450 | ||||||
| Cash Flow from Financing | 580.6430 | -317.2860 | -764.6320 | -128.3630 | 422.8740 | ||||||
| Decrease / Increase in Cash | -41.5730 | 316.0280 | -167.8780 | -21.5680 | -45.8190 | ||||||
| Employees | 7,240 | 7,700 | - | - | - | ||||||
